The response to docetaxel and cyclophosphamide treatment is monitored through regular follow-up appointments, which may include physical examinations, imaging tests such as CT or MRI scans, and blood tests. These assessments help determine how well the cancer is responding to the treatment and whether any adjustments to the therapy are necessary.
